Skip to main content

Advertisement

SpringerLink
Log in

Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Umbilical cord-derived mesenchymal stem cell transplantation (UC-MSCT) has been proved to be effective in the treatment of systemic lupus erythematosus (SLE), based on animal experiments and clinical trials. Diffuse alveolar hemorrhage (DAH) is a rare complication of SLE with a high mortality usually over 50%. This study aimed to assess the efficacy of UC-MSCT in the treatment of SLE-associated DAH. Four SLE patients complicated with DAH, who underwent UC-MSCT, were included. Clinical changes before and after transplantation were assessed by measurements of hemoglobin, platelet level, oxygen saturation, and serological factors. High-resolution CT (HRCT) scans of the chest were performed to evaluate pulmonary manifestation. All the four patients showed dramatic improvements of their clinical manifestations. Hemoglobin was elevated after UC-MSCT and was sustained at a normal level 6 months after UC-MSCT in the four patients. Platelet level was upregulated in two patients who had thrombocytopenia at baseline. Oxygen saturation appeared to be normal at 1 month after UC-MSCT, and this result was confirmed by the HRCT scan of the chest. Serum albumin elevated to 3.5 g/dl 6 months after transplantation. Our findings suggest that UC-MSCT results in amelioration of oxygen saturation as well as hematological and serologic changes, which revealed that UC-MSCT could be applied as a salvage strategy for DAH patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Chang MY, Fang JT, Chen YC et al (2002) Diffuse alveolar hemorrhage in systemic lupus erythematosus: a single center retrospective study in Taiwan. Ren Fail 24:791–802

    Article  PubMed  Google Scholar 

  2. Canas C, Tobon GJ, Granados M et al (2007) Diffuse alveolar hemorrhage in Colombian patients with systemic lupus erythematosus. Clin Rheumatol 26:1947–1949

    Article  PubMed  Google Scholar 

  3. Shen M, Zeng X, Tian X et al (2010) Diffuse alveolar hemorrhage in systemic lupus erythematosus: a retrospective study in China. Lupus 19:1326–1330

    Article  PubMed  CAS  Google Scholar 

  4. Kwok SK, Moon SJ, Ju JH et al (2011) Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea. Lupus 20:102–107

    Article  PubMed  Google Scholar 

  5. Martinez-Martinez MU, Abud-Mendoza C (2011) Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus. Lupus 20:568–574

    Article  PubMed  CAS  Google Scholar 

  6. Hughson MD, He Z, Henegar J et al (2001) Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus: immune complex small vascular injury with apoptosis. Arch Pathol Lab Med 125:475–483

    PubMed  CAS  Google Scholar 

  7. Santos-Ocampo AS, Mandell BF, Fessler BJ (2000) Alveolar hemorrhage in systemic lupus erythematosus. Chest 118:1083–1090

    Article  PubMed  CAS  Google Scholar 

  8. Badsha H, The CL, Kong KO et al (2003) Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 33:414–421

    Article  Google Scholar 

  9. Nellessen CM, Poge U, Brensing KA et al (2008) Diffuse alveolar haemorrhage in a systemic lupus erythematosus patient successfully treated with rituximab: a case report. Nephrol Dial Transplant 23:385–386

    Article  PubMed  Google Scholar 

  10. Narshi CB, Haider S, Ford CM et al (2010) Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus. Rheumatology 49:392–394

    Article  PubMed  CAS  Google Scholar 

  11. Pottier V, Pierrot M, Subra JF et al (2011) Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage. Lupus 20:656–659

    Article  PubMed  CAS  Google Scholar 

  12. Young HE, Mancini ML, Wright RP et al (1995) Mesenchymal stem cells reside within the connective tissues of many organs. Dev Dyn 202:137–144

    Article  PubMed  CAS  Google Scholar 

  13. Williams JT, Southerland SS, Souza J et al (1999) Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg 65:22–26

    PubMed  CAS  Google Scholar 

  14. Zuk PA, Zhu M, Mizuno H et al (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211–228

    Article  PubMed  CAS  Google Scholar 

  15. Erices A, Conget P, Minguell JJ (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235–242

    Article  PubMed  CAS  Google Scholar 

  16. Liang J, Gu F, Wang H et al (2010) Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE. Nat Rev Rheumatol 6:486–489

    Article  PubMed  Google Scholar 

  17. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  PubMed  CAS  Google Scholar 

  18. Zhou K, Zhang H, Jin O et al (2008) Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol 5:417–424

    Article  PubMed  Google Scholar 

  19. Sun L, Akiyama K, Zhang H et al (2009) Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27:1421–1432

    Article  PubMed  CAS  Google Scholar 

  20. Gu Z, Akiyama K, Ma X et al (2010) Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus 19:1502–1514

    Article  PubMed  CAS  Google Scholar 

  21. Sun L, Wang D, Liang J et al (2010) Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 62:2467–2475

    Article  PubMed  CAS  Google Scholar 

  22. Liang J, Zhang H, Hua B et al (2010) Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 69:1423–1429

    Article  PubMed  Google Scholar 

  23. Gupta N, Su X, Popov B et al (2007) Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179:1855–1863

    PubMed  CAS  Google Scholar 

  24. Sun J, Han ZB, Liao W et al (2011) Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ Forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti- and pro-inflammatory factors. Cell Physiol Biochem 27:587–596

    Article  PubMed  CAS  Google Scholar 

  25. Kim ES, Chang YS, Choi SJ et al (2011) Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice. Respir Res 12:108

    Article  PubMed  CAS  Google Scholar 

  26. Lee JW, Fang X, Gupta N et al (2009) Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 106:16357–16362

    Article  PubMed  CAS  Google Scholar 

  27. Carrion F, Nova E, Ruiz C et al (2010) Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus 19:317–322

    Article  PubMed  CAS  Google Scholar 

  28. Sun LY, Zhang HY, Feng XB et al (2007) Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 16:121–128

    Article  PubMed  CAS  Google Scholar 

  29. Barker TT, Lee PY, Kelly-Scumpia KM et al (2011) Pathogenic role of B cells in the development of diffuse alveolar hemorrhage induced by pristine. Lab Invest 91:1540–1550

    Article  PubMed  CAS  Google Scholar 

  30. Koh H, Nakamae H, Koh KR et al (2010) Serum cytokine profiles at the onset of severe, diffuse alveolar hemorrhage complicating allogeneic hematopoietic stem cell transplantation, treated successfully with pulse intravenous cyclophosphamide. Acta Haematol 124:171–175

    Article  PubMed  Google Scholar 

  31. Krause DS, Theise ND, Collector MI et al (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cells. Cell 105:369–377

    Article  PubMed  CAS  Google Scholar 

  32. Kopen GC, Prockop DJ, Phinney DG (1999) Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 96:10711–10716

    Article  PubMed  CAS  Google Scholar 

  33. Kotton DN, Ma BY, Cardoso WV et al (2001) Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128:5181–5188

    PubMed  CAS  Google Scholar 

  34. Lara AR, Schwarz MI (2010) Diffuse alveolar hemorrhage. Chest 137:1164–1171

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (nos. 81072473, 81172847, and 30972736), the Jiangsu Province Natural Science Foundation (no. BK2009034), the Major International (Regional) Joint Research Project (no. 81120108021), and the Jiangsu Province Ke Jiao Xing Wei Program.

Disclosures

None.

Author information

Authors and Affiliations

  1. Department of Immunology and Rheumatology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People’s Republic of China

    Dongyan Shi, Dandan Wang, Xia Li, Huayong Zhang & Lingyun Sun

  2. Department of Immunology and Rheumatology, Drum Tower Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of China

    Nan Che & Zhimin Lu

Authors
  1. Dongyan Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dandan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xia Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Huayong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nan Che
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhimin Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lingyun Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lingyun Sun.

Additional information

Dongyan Shi and Dandan Wang are co-first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shi, D., Wang, D., Li, X. et al. Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus. Clin Rheumatol 31, 841–846 (2012). https://doi.org/10.1007/s10067-012-1943-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-012-1943-2

Keywords

Search

Navigation